Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Endometrial Cancer in Germline BRCA Mutation Carriers: A Systematic Review and Meta-analysis.

Journal of minimally invasive gynecology - 1 May 2021

Matanes Emad, Volodarsky-Perel Alexander, Eisenberg Neta, Rottenstreich Misgav, Yasmeen Amber, Mitric Cristina, Lau Susie, Salvador Shannon, Gotlieb Walter H, Kogan Liron

Abstract excerpt

OBJECTIVE: Risk-reducing salpingo-oophorectomy (RRSO) is standard treatment among women with BRCA mutations. The aim of this meta-analysis is to evaluate the risk of endometrial cancer (EC) in BRCA1 or BRCA2 germline mutation carriers and to examine the justifiability of prophylactic hysterectomy at the time of RRSO. DATA SOURCES: PubMed, Cochrane Central Register of Controlled Trials, BIOSIS, Medline (Ovid), Web...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA2 Protein
Share to Breast Neoplasms

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Endometrial Neoplasms

Share to Genes, BRCA2

Share to Germ Cells

Share to Germ-Line Mutation

Share to Ovarian Neoplasms

Share to Ovariectomy

Source

Identifiers

PMID: 33249269
DOI: 10.1016/j.jmig.2020.11.023

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Endometrial Cancer in Germline BRCA Mutation Carriers: A Systematic Review and Meta-analysis.PMID 33249269Read ↗

Uterine Cancer After Risk-Reducing Salpingo-oophorectomy Without Hysterectomy in Women With BRCA Mutations.Semantic proximity Read ↗

Association between BRCA mutations and endometrial carcinoma: a systematic review with meta-analysis.Semantic proximity Read ↗

Endometrial Cancer Risk in Women With Germline BRCA1 or BRCA2 Mutations: Multicenter Cohort Study.Semantic proximity Read ↗

Incidence of endometrial cancer in BRCA mutation carriers.Semantic proximity Read ↗

Impact of BRCA mutations on outcomes among patients with serous endometrial cancer.Semantic proximity Read ↗

Hereditary Women's Cancer: Management and Risk-Reducing Surgery.Semantic proximity Read ↗

Ovarian cancer risk management in BRCA-mutation carriers: A comparison of six international and national guidelines.Semantic proximity Read ↗

Risk-reducing salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers.Semantic proximity Read ↗

High-Grade Serous Carcinoma at Risk-Reducing Salpingo-Oophorectomy in Asymptomatic Carriers of BRCA1/2 Pathogenic Variants: Prevalence and Clinical Factors.Semantic proximity Read ↗

Risk of endometrial cancer after RRSO in BRCA 1/2 carriers: a multicentre cohort study.Semantic proximity Read ↗

Risk-reducing salpingo-oophorectomy and breast cancer risk in BRCA1 or BRCA2 mutation carriers: A systematic review and meta-analysis.Semantic proximity Read ↗

Risk of uterine cancer for BRCA1 and BRCA2 mutation carriers.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.